Breaking News Headlines Today | Ground News

See every side of every news story

citybuzz.co image

News from citybuzz.co

We’ve assigned a media bias rating of unknown to citybuzz.co. You can read more about our methodology here.

citybuzz.co’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about citybuzz.co

Where is citybuzz.co located?citybuzz.co's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top citybuzz.co News

Cuffless Blood Pressure Devices Show Great Promise as Alternatives to Traditional Arm-Cuff Monitors

Cuffless Blood Pressure Devices Show Great Promise as Alternatives to Traditional Arm-Cuff Monitors

100% Center coverage: 2 sources

Cuffless devices to measure blood pressure, such as smartwatches, rings, patches and fingertip monitors, show great promise as alternatives to traditional arm-cuff monitors, however, they are not yet proven accurate enough to diagnose high blood pressure or guide treatment decisions, according to a new scientific statement published today in the American Heart Association's journal Hypertension.See the Story

2026 Hong Kong Export Growth of 8-9%, Sustained AI Product Demand Lays Solid Foundation for Future Expansion – DIR HONGKONG

Artificial Intelligence · Hong Kong

2026 Hong Kong Export Growth of 8-9%, Sustained AI Product Demand Lays Solid Foundation for Future Expansion – DIR HONGKONG

Open the article to view the coverage from dirhongkong.com See the Story

HeartBeam Secures FDA Clearance for 12-Lead ECG Synthesis Software Following Appeal – Citybuzz

United States · United States

HeartBeam Secures FDA Clearance for 12-Lead ECG Synthesis Software Following Appeal – Citybuzz

HeartBeam Inc. (NASDAQ: BEAT) has received FDA 510(k) clearance for its 12-lead ECG synthesis software for arrhythmia assessment following a successful appeal of a prior not substantially equivalent (NSE) determination. The clearance represents a significant regulatory milestone for the medical technology company, which focuses on transforming cardiac care through personalized insights. The company’s patented cable-free technology captures cardi…See the Story

Breaking News Topics Related to citybuzz.co